This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Tumor cell heterogeneity reshapes cancer cure effort
New insights from Johns Hopkins and Yale researchers emphasize tumor cell diversity within cancers. Variation drives drug resistance and spread, explaining why radiation and single-drug therapies fail and why combination treatments may offer better control. Researchers gathered at the Bristol-Myers Symposium in Baltimore underscored evolution-like selection within tumors.
MENTIONED IN THIS ARTICLE
Clement L. Markert
Yale University
Peter C. Nowell
University of Pennsylvania School of Medicine
Bristol-Myers
Baltimore
Johns Hopkins Medical School
Coffey